SEC Form 4 · accession 0001127602-19-009111
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 27, 2019
Accepted (ET)
Mar 1, 2019 · 11:22 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2019 | S | 144 | $142.45 | D | 279,569 | D | |
| Common Stock | Feb 27, 2019 | S | 200 | $142.49 | D | 279,369 | D | |
| Common Stock | Feb 27, 2019 | S | 169 | $142.51 | D | 279,200 | D | |
| Common Stock | holding | — | — | — | 18,390 | I | 2017 GRAT | |
| Common Stock | holding | — | — | — | 25,000 | I | 2018 GRAT | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.